bpc-157 fda compounding category Peptide Review 2026: What This Big Shift Means HIMS jumps more than 7%
HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer FDA Peptide Update: Category 2 Removals Explained 83% of peptide aware Americans want the FDA to make peptides more accessible AOL Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand Health Law Alliance
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



